Pradhan Avani, Mishra Prabhakar, Tiwari Swasti, Choure Kamlesh, Gupta Amrit
Department of Molecular Medicine and Biotechnology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Department of Biotechnology, AKS University, Satna, Madhya Pradesh, India.
Int J Appl Basic Med Res. 2022 Oct-Dec;12(4):277-283. doi: 10.4103/ijabmr.ijabmr_155_22. Epub 2022 Dec 19.
Aneuploidy screening is done in the early second trimester of pregnancy among all pregnant women as compulsory, with a special focus on those who had abnormal ultrasound parameters, higher dual marker risk, or other comorbidities. Recently, all individual quad markers of conventional trisomy screening have been suggested as useful in predicting adverse pregnancy outcomes (APO) such as preeclampsia, preterm labor, small for gestational age, and placental abruptions. However, similar studies on Indian pregnant women are limited. Hence, this study was intended to find the relation of quadruple markers with any other APO than aneuploidy.
A retrospective study was conducted in a Tertiary Care multi-specialty hospital in North India. Data from 252 pregnant women's quadruple test was analyzed. The association of abnormal value of quadruple markers (human chorionic gonadotropin [HCG]/alpha-fetoprotein/uE3/Inhibin A) with adverse outcomes was evaluated. Multiple logistic regression analysis and classification and regression tree were used to predict the significant risk factor in high-risk pregnancies.
In the study, a total ( = 252) of pregnant women, 190 were screened as high-risk pregnancies, whereas the remaining 62 were reported as low-risk using trisomy screening in the quadruple test. Baby birth weight was observed to be significantly associated with Inhibin-A, and HCG ( < 0.001), whereas Corrected (Corr)-multiple of median (MoM)-HCG (>1.415) and Inhibin-A Corr-MoM (>364.175) were the suitable predictor for the LBW. Both parameters were significantly higher in the high-risk group as compared to the low-risk group (each < 0.05).
Abnormal deviation of biochemical markers from aneuploidy screening assessment could help predict other perinatal adverse outcomes such as low birth weight babies.
在妊娠中期早期,对所有孕妇进行非整倍体筛查是强制性的,尤其关注那些超声参数异常、二联标志物风险较高或有其他合并症的孕妇。最近,传统三体筛查的所有单项四联标志物都被认为有助于预测不良妊娠结局(APO),如先兆子痫、早产、小于胎龄儿和胎盘早剥。然而,针对印度孕妇的类似研究有限。因此,本研究旨在探究四联标志物与除非整倍体之外的其他不良妊娠结局之间的关系。
在印度北部的一家三级护理多专科医院进行了一项回顾性研究。分析了252名孕妇的四联检测数据。评估了四联标志物(人绒毛膜促性腺激素[HCG]/甲胎蛋白/uE3/抑制素A)异常值与不良结局之间的关联。采用多元逻辑回归分析和分类回归树来预测高危妊娠中的显著危险因素。
在该研究中,共有252名孕妇,其中190名在四联检测中通过三体筛查被筛查为高危妊娠,而其余62名被报告为低危妊娠。观察到婴儿出生体重与抑制素A和HCG显著相关(P<0.001),而校正后(Corr)的中位数倍数(MoM)-HCG(>1.415)和抑制素A Corr-MoM(>364.175)是低出生体重的合适预测指标。与低危组相比,高危组的这两个参数均显著更高(均P<0.05)。
非整倍体筛查评估中生化标志物的异常偏差有助于预测其他围产期不良结局,如低出生体重儿。